NCT06225622 2024-03-19Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal CancerShanghai Zhongshan HospitalPhase 1 Unknown78 enrolled